✦ LIBER ✦

Challenges in therapy of chronic hepatitis B

✍ Scribed by Jay H Hoofnagle

Book ID: 117371970
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 99 KB
Volume: 39
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)00332-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral therapy of chronic hepatitis B

Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia

✍ Yun-Fan Liaw 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Antiviral therapy for chronic hepatitis

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

✍ Henry Lik-Yuen Chan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Endpoints of therapy in chronic hepatiti

Endpoints of therapy in chronic hepatitis B

✍ Jordan J. Feld; David K. H. Wong; E. Jenny Heathcote 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Because clearance of hepatitis B virus (HBV) infection is rarely, if ever, achievable, the goals of therapy necessarily focus on prevention of bad clinical outcomes. Ideally, therapies would be shown to prevent tangible clinical endpoints like development of cirrhosis, end-stage liver disease and he

Antiviral therapy of chronic hepatitis B

✍ Fabien Zoulim 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Current Therapy of Chronic Hepatitis B

✍ Margarita Pardo; Javier Bartolomé; Vicente Carreño 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Interferon therapy in hepatitis B e anti

Interferon therapy in hepatitis B e antigen–negative chronic hepatitis B

✍ Agostino Colli; Sara Massironi; Marco Anreoletti 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB